With Naurex, Allergan potentially expands its development of mental health treatments, as the acquired company’s focus is on developing therapies for brain and nervous system disorders like depression.
Vaccine exemption levels for kindergarteners are low for most states and infant vaccination rates are high nationwide, according to the week’s Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention.
The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.
Vermont on Friday became the last state in the nation to legalize electronic prescriptions for controlled substances — a measure that many states have adopted as a way to combat the abuse of controlled substances and prevent individuals from resorting to fraudulent paper prescriptions.
Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.
Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders.
Dr. Reddy’s Laboratories on Thursday announced several senior level changes in their global management structure.
Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
When asked about readiness in the face of a cyber-attack, 66% of executives at health plans said they were prepared, while only 53% of providers said they were ready.